Association Between Diabetes and Mortality Among Adult Patients Hospitalized With COVID-19: A Cohort Study of Hospitalized Adults in Ontario, Canada, and Copenhagen, Denmark
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Association Between Diabetes and Mortality Among Adult Patients Hospitalized With COVID-19 : A Cohort Study of Hospitalized Adults in Ontario, Canada, and Copenhagen, Denmark. / Bogler, Orly; Raissi, Afsaneh; Colacci, Michael; Beaman, Andrea; Biering-Sørensen, Tor; Cressman, Alex; Detsky, Allan; Gosset, Alexi; Lassen, Mats Højbjerg; Kandel, Chris; Khaykin, Yaariv; Barbosa, David; Lapointe-Shaw, Lauren; MacFadden, Derek R.; Pearson, Alexander; Perkins, Bruce A.; Rothman, Kenneth J.; Skaarup, Kristoffer Grundtvig; Weagle, Rachael; Yarnell, Chris; Sholzberg, Michelle; Hodzic-Santor, Benazir; Lovblom, Erik; Zipursky, Jonathan; Quinn, Kieran L.; Fralick, Mike.
In: Canadian Journal of Diabetes, Vol. 47, No. 4, 2023, p. 352-358.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Association Between Diabetes and Mortality Among Adult Patients Hospitalized With COVID-19
T2 - A Cohort Study of Hospitalized Adults in Ontario, Canada, and Copenhagen, Denmark
AU - Bogler, Orly
AU - Raissi, Afsaneh
AU - Colacci, Michael
AU - Beaman, Andrea
AU - Biering-Sørensen, Tor
AU - Cressman, Alex
AU - Detsky, Allan
AU - Gosset, Alexi
AU - Lassen, Mats Højbjerg
AU - Kandel, Chris
AU - Khaykin, Yaariv
AU - Barbosa, David
AU - Lapointe-Shaw, Lauren
AU - MacFadden, Derek R.
AU - Pearson, Alexander
AU - Perkins, Bruce A.
AU - Rothman, Kenneth J.
AU - Skaarup, Kristoffer Grundtvig
AU - Weagle, Rachael
AU - Yarnell, Chris
AU - Sholzberg, Michelle
AU - Hodzic-Santor, Benazir
AU - Lovblom, Erik
AU - Zipursky, Jonathan
AU - Quinn, Kieran L.
AU - Fralick, Mike
N1 - Publisher Copyright: © 2023 Canadian Diabetes Association
PY - 2023
Y1 - 2023
N2 - Objectives: Diabetes has been reported to be associated with an increased risk of death among patients with COVID-19. However, the available studies lack detail on COVID-19 illness severity and measurement of relevant comorbidities. Methods: We conducted a multicentre, retrospective cohort study of patients 18 years of age and older who were hospitalized with COVID-19 between January 1, 2020, and November 30, 2020, in Ontario, Canada, and Copenhagen, Denmark. Chart abstraction emphasizing comorbidities and disease severity was performed by trained research personnel. The association between diabetes and death was measured using Poisson regression. The main outcome measure was in-hospital 30-day risk of death. Results: Our study included 1,133 hospitalized patients with COVID-19 in Ontario and 305 in Denmark, of whom 405 and 75 patients, respectively, had pre-existing diabetes. In both Ontario and Denmark, patients with diabetes were more likely to be older; have chronic kidney disease, cardiovascular disease, and higher troponin levels; and be receiving antibiotics, when compared with adults without diabetes. In Ontario, 24% (n=96) of adults with diabetes died compared with 15% (n=109) of adults without diabetes. In Denmark, 16% (n=12) of adults with diabetes died in hospital compared with 13% (n=29) of those without diabetes. In Ontario, the crude mortality ratio among patients with diabetes was 1.60 (95% confidence interval [CI], 1.24 to 2.07) and in the adjusted regression model it was 1.19 (95% CI, 0.86 to 1.66). In Denmark, the crude mortality ratio among patients with diabetes was 1.27 (95% CI, 0.68 to 2.36) and in the adjusted model it was 0.87 (95% CI, 0.49 to 1.54). Meta-analysis of the 2 rate ratios from each region resulted in a crude mortality ratio of 1.55 (95% CI, 1.22 to 1.96) and an adjusted mortality ratio of 1.11 (95% CI, 0.84 to 1.47). Conclusion: The presence of diabetes was not strongly associated with in-hospital COVID-19 mortality independent of illness severity and other comorbidities.
AB - Objectives: Diabetes has been reported to be associated with an increased risk of death among patients with COVID-19. However, the available studies lack detail on COVID-19 illness severity and measurement of relevant comorbidities. Methods: We conducted a multicentre, retrospective cohort study of patients 18 years of age and older who were hospitalized with COVID-19 between January 1, 2020, and November 30, 2020, in Ontario, Canada, and Copenhagen, Denmark. Chart abstraction emphasizing comorbidities and disease severity was performed by trained research personnel. The association between diabetes and death was measured using Poisson regression. The main outcome measure was in-hospital 30-day risk of death. Results: Our study included 1,133 hospitalized patients with COVID-19 in Ontario and 305 in Denmark, of whom 405 and 75 patients, respectively, had pre-existing diabetes. In both Ontario and Denmark, patients with diabetes were more likely to be older; have chronic kidney disease, cardiovascular disease, and higher troponin levels; and be receiving antibiotics, when compared with adults without diabetes. In Ontario, 24% (n=96) of adults with diabetes died compared with 15% (n=109) of adults without diabetes. In Denmark, 16% (n=12) of adults with diabetes died in hospital compared with 13% (n=29) of those without diabetes. In Ontario, the crude mortality ratio among patients with diabetes was 1.60 (95% confidence interval [CI], 1.24 to 2.07) and in the adjusted regression model it was 1.19 (95% CI, 0.86 to 1.66). In Denmark, the crude mortality ratio among patients with diabetes was 1.27 (95% CI, 0.68 to 2.36) and in the adjusted model it was 0.87 (95% CI, 0.49 to 1.54). Meta-analysis of the 2 rate ratios from each region resulted in a crude mortality ratio of 1.55 (95% CI, 1.22 to 1.96) and an adjusted mortality ratio of 1.11 (95% CI, 0.84 to 1.47). Conclusion: The presence of diabetes was not strongly associated with in-hospital COVID-19 mortality independent of illness severity and other comorbidities.
KW - care processes
KW - comorbidities
KW - COVID-19
KW - COVID-19 mortality
KW - COVID-19 severity
KW - diabetes
U2 - 10.1016/j.jcjd.2023.02.005
DO - 10.1016/j.jcjd.2023.02.005
M3 - Journal article
C2 - 37074240
AN - SCOPUS:85152969837
VL - 47
SP - 352
EP - 358
JO - Canadian Journal of Diabetes
JF - Canadian Journal of Diabetes
SN - 1499-2671
IS - 4
ER -
ID: 370480970